BioNTech SE

cachedupdated

appsKey Facts

This company profile is a search result of implisense.com

  • Size (Revenue & Employees)
    Large company
  • Legal Form
    Europäische Aktiengesellschaft (SE)
  • Incorporation
  • Commercial Register
    Mainz
    HRB 48720
  • Capital Stock
    € 246,310,081.00
    Register for free
  • Economic State
    Active
  • Historical Names
    • BioNTech AG
  • Purpose
    Die Erforschung und Entwicklung, die Herstellung und die Vermarktung von immunologischen und von RNA-basierten Arzneimitteln und Testverfahren zur Diagnostik, Vorbeugung und Therapie von Krebserkrankungen, Infektionskrankheiten und anderen schwerwiegenden Krankheiten.
  • Address
    An der Goldgrube 12, 55131 Mainz

Register your Implisense account for free

Register quickly and easily with a free Implisense account. Registered users have access to advanced analyses and more key figures on company profiles, receive more extensive search results and can also create and manage their own favorites.

  • content_copy
    Richer Company Profiles
  • search
    Expanded Search Results
  • star_border
    Personal Favourites and Notes

linear_scaleTimeline

Register Filings
Veränderung im Handelsregister

Die Hauptversammlung vom 26.06.2020 hat die Änderung der Satzung in § 4 Absatz 5 (Höhe und Einteilung des Grundkapitals, genehmigtes Kapital), § 14 (Ort und Einberufung) und § 16 (Verfahren, Niederschrift) beschlossen.

Registergerichte der Länder der Bundesrepublik Deutschland
Register Filings
Veränderung im Handelsregister

Erhöhung des Grundkapitals um weitere 2.595.996,00 EUR durchgeführt. Durch Beschluss des Aufsichtsrates vom 21.08.2020 ist § 4 Abs. 1 und Abs. 5 (Höhe und Einteilung des Grundkapitals) der Satzung (Höhe und Einteilung des Grundkapitals) geändert. Neues Grundkapital: 246.310.081,00 EUR. Das genehmigte Kapital 2019 beträgt nunmehr noch EUR 91.812.171,00.

Registergerichte der Länder der Bundesrepublik Deutschland
Register Filings
Veränderung im Handelsregister

Erhöhung des Grundkapitals um weitere 16.124,00 EUR durchgeführt. Durch Beschluss des Aufsichtsrates vom 19.08.2020 ist die Satzung in § 4 Abs. 1 und Abs. 5 (Höhe und Einteilung des Grundkaptials) geändert. Neues Grundkapital: 243.714.085,00 EUR. Das genehmigte Kapital 2019 beträgt nunmehr noch EUR 94.408.167,00.

Registergerichte der Länder der Bundesrepublik Deutschland
Register Filings
Veränderung im Handelsregister

Erhöhung des Grundkapitals um weitere 5.500.000,00 EUR durchgeführt. Durch Beschluss des Aufsichtsrates vom 22.07.2020 ist die Satzung in § 4 Abs. 1 und Abs. 5 (Höhe und Einteilung des Grundkapitals) geändert. Neues Grundkapital: 243.697.961,00 EUR. Das genehmigte Kapital 2019 beträgt nunmehr noch EUR 94.424.291,00.

Registergerichte der Länder der Bundesrepublik Deutschland
Register Filings
Veränderung im Handelsregister

Vorstand: Richardson, Ryan Jeffrey, Mainz, *XX.XX.XXXX, vertretungsberechtigt gemäß allgemeiner Vertretungsregelung.

Registergerichte der Länder der Bundesrepublik Deutschland

assessmentProducts & Services

Vaccine
Genomics
Entwicklung
Biotechnologie
Software
Immuntherapie
Fonds
Produktion
Holdings
See all 20 entries

Register for a free Implisense account to get advanced analysis and more extensive search results.

add_circleImplisense Account

BioNTech SE is mentioned in public sources in the context of the following products and services. Vaccine, Genomics and Entwicklung are the most common. The ranking list shown is without guarantee of completeness or correctness.

spaValue Profile

Dominance, Competence, ClarityInnovation, Passion, CreativityHarmony, Reliability, CommunicatibilityDilligence, Introspection, Thoroughness
Dominance, Competence, Clarity
Innovation, Passion, Creativity
Harmony, Reliability, Communicatibility
Dilligence, Introspection, Thoroughness

The 4 Color Scheme separates people and their personalities into four groups. BioNTech SE emphasizes the following character types in their external communications and job advertisements.

You can find more information on the FAQ page.

cakeOffers for Job Seekers

The following benefits were repeatedly recognized in job postings of BioNTech SE. This data is supplied without liability and intended for orientation purposes only.

TeamkulturFlache Hierarchien
MitarbeiterförderungWeiterbildungsangebote
Karrierechancen
Weitere BenefitsArbeitsplatzsicherheit
Betriebsrat
Umsatzbeteiligung
BenefitsWork-Life-Balance
Work-Life-BalanceFlexible Arbeitszeiten
Kinderbetreuung
See all 10 entries

Register for a free Implisense account to get advanced analysis and more extensive search results.

add_circleImplisense Account

The following types of employment were recognized in job advertisements. The types of employment can vary depending on the position and serve as a guide.

  • checkmark
    Ausbildung
  • checkmark
    Festanstellung
  • checkmark
    Befristete Anstellung

location_onInternational affairs

AfghanistanAngolaAlbaniaUnited Arab EmiratesArgentina: 2ArmeniaAustralia: 26Austria: 26AzerbaijanBurundiBelgiumBeninBurkina FasoBangladeshBulgariaBosnia and HerzegovinaBelarusBelizeBoliviaBrazil: 2Brunei DarussalamBhutanBotswanaCentral African RepublicCanada: 36Switzerland: 29Chile: 6China: 100Côte d'IvoireCameroonDemocratic Republic of the CongoCongoColombiaCosta RicaCubaCzechiaGermanyDjiboutiDenmark: 6Dominican RepublicAlgeriaEcuadorEgyptEritreaEstoniaEthiopiaFinlandFijiGabonUnited Kingdom of Great Britain and Northern IrelandGeorgiaGhanaGuinea: 4GambiaGuinea-BissauEquatorial GuineaGreeceGreenlandGuatemalaGuyanaHondurasCroatiaHaitiHungaryIndonesia: 6India: 54IrelandIslamic Republic of Iran: 4IraqIceland: 5Israel: 25ItalyJamaicaJordanJapan: 60KazakhstanKenyaKyrgyzstanCambodiaRepublic of South Korea: 17KuwaitLao People's Democratic RepublicLebanonLiberiaLibyaSri LankaLesothoLithuaniaLuxembourgLatviaMoroccoRepublic of MoldovaMadagascarMexico: 6MacedoniaMaliMyanmarMontenegroMongoliaMozambiqueMauritaniaMalawiMalaysia: 3NamibiaNigerNigeria: 3NicaraguaNetherlands: 3NorwayNepalNew Zealand: 10OmanPakistanPanamaPeru: 3PhilippinesPapua New GuineaPolandDemocratic People's Republic of KoreaPortugalParaguayState of PalestineQatarRomaniaRussian FederationRwandaWestern SaharaSaudi Arabia: 2SudanSouth SudanSenegalSierra LeoneEl SalvadorSerbiaSurinameSlovakia: 2SloveniaSwedenEswatiniSyrian Arab RepublicChadTogoThailandTajikistanTurkmenistanTimor-LesteTunisiaTurkey: 2TaiwanUnited Republic of TanzaniaUgandaUkraineUruguayUnited States of America: 66UzbekistanVenezuelaViet Nam: 2VanuatuYemenSouth Africa: 7ZambiaZimbabweSomaliaFrench GuianaFrance: 2Spain: 4ArubaAnguillaAntigua and BarbudaBahamasBermudaBarbadosComorosCabo VerdeCayman IslandsDominicaFalkland IslandsFaroe IslandsGrenadaHong KongSaint Kitts and NevisSaint LuciaLiechtensteinMaldivesMaltaMontserratMauritiusNew CaledoniaNauruPitcairnPuerto RicoFrench PolynesiaSingaporeSolomon IslandsSao Tome and PrincipeSint MaartenSeychellesTurks and Caicos IslandsTongaTrinidad and TobagoSaint Vincent and the GrenadinesVirgin IslandsVirgin IslandsCyprusRéunionMayotteMartiniqueGuadeloupeCuraçaoIc

BioNTech SE was recently referenced in connection with the following countries in press releases, job postings, register filings, and associated social media channels. China, United States of America and Japan were mentioned in this context with the highest frequency.

memoryTechnology Profile

Application Performance ManagementNew Relic
Application Programming InterfacesAPI
Artificial IntelligenceKünstliche Intelligenz
Maschinelles Lernen
AutomationAutomation Technology
Autonomous DrivingSelbstfahrende Fahrzeuge
Big DataBig Data Technology
Hive
NoSql
See all 59 entries

Register for a free Implisense account to get advanced analysis and more extensive search results.

add_circleImplisense Account

The following software solutions, technologies and concepts are often referenced in job postings and press releases of BioNTech SE. Most frequently recognized were ERP-System, CRM-System and Robotik.

codeIntegration via API

content_copy
  1. curl \
  2. --silent \
  3. --request GET \
  4. --header "Content-Type: application/json" \
  5. --url "https://implisen.se/DEFV42JQR896" | jq '.'
play_arrow
  •  
content_copy
  1. require 'json'
  2. require 'net/http'
  3. uri = URI('https://implisen.se/DEFV42JQR896')
  4. response = Net::HTTP.get(uri)
  5. puts JSON.parse(response)
play_arrowcontent_copy
  •  
content_copy
  1. const https = require('https');
  2. https.get('https://implisen.se/DEFV42JQR896', (response) => {
  3. let data = '';
  4. response.on('data', (chunk) => {
  5. data += chunk;
  6. });
  7. response.on('end', () => {
  8. console.log(JSON.parse(data));
  9. });
  10. });
play_arrowcontent_copy
  •  
content_copy
  1. import urllib.request
  2. import json
  3. from pprint import pprint
  4. response = urllib.request.urlopen('https://implisen.se/DEFV42JQR896').read()
  5. pprint(json.loads(response))
play_arrowcontent_copy
  •  
content_copy
  1. package main
  2. import( "net/http"
  3. "io/ioutil"
  4. "bytes"
  5. "encoding/json"
  6. "fmt"
  7. func main() {
  8. response, _ := http.Get("https://implisen.se/DEFV42JQR896")
  9. defer response.Body.Close()
  10. payload, _ := ioutil.ReadAll(response.Body)
  11. var out bytes.Buffer
  12. json.Indent(&out, payload, "", " ")
  13. fmt.Println(string(out.Bytes()))
play_arrowcontent_copy
  •  

With the Implisense API you can enrich your CRM or ERP system with public data on over 2 million companies. Via the RapidAPI marketplace you can directly access our API. For further information, please refer to our internal page on the Implisense API.

Register your Implisense account for free

Register quickly and easily with a free Implisense account. Registered users have access to advanced analyses and more key figures on company profiles, receive more extensive search results and can also create and manage their own favorites.

  • content_copy
    Richer Company Profiles
  • search
    Expanded Search Results
  • star_border
    Personal Favourites and Notes
The information presented on implisense.com comes from public sources and is verified and aggregated automatically. Implisense cannot guarantee the timeliness, completeness, quality, reliability or accuracy of the data. For questions or suggestions, please use the contact form.

This website uses cookies to provide this service and improve the user experience. Please select the cookies you wish to accept. You can find further information in our data protection declaration.

Some cookies from this site are necessary for the functionality of this service or enhance the user experience. Since these cookies either do not contain any personal data (e.g. language preference) or are very short-lived (e.g. session ID), cookies from this group are mandatory and cannot be deactivated.
To improve our services, we use user statistics such as Matomo and Google Analytics, which set cookies for user identification. While Google Analytics is a service offered by a third party provider, Matomo is operated by Implisense GmbH, all collected data is not made available to third parties.
To improve our services we use proprietary marketing solutions from third parties. These solutions specifically include Google AdWords and Google Optimize, which each set one or more cookies.
Some cookies from this site are necessary for the functionality of this service or enhance the user experience. Since these cookies either do not contain any personal data (e.g. language preference) or are very short-lived (e.g. session ID), cookies from this group are mandatory and cannot be deactivated.Some cookies from this site are necessary for the functionality of this service or enhance the user experience. Since these cookies either do not contain any personal data (e.g. language preference) or are very short-lived (e.g. session ID), cookies from this group are mandatory and cannot be deactivated.
To improve our services, we use user statistics such as Matomo and Google Analytics, which set cookies for user identification. While Google Analytics is a service offered by a third party provider, Matomo is operated by Implisense GmbH, all collected data is not made available to third parties.Some cookies from this site are necessary for the functionality of this service or enhance the user experience. Since these cookies either do not contain any personal data (e.g. language preference) or are very short-lived (e.g. session ID), cookies from this group are mandatory and cannot be deactivated.
To improve our services we use proprietary marketing solutions from third parties. These solutions specifically include Google AdWords and Google Optimize, which each set one or more cookies.Some cookies from this site are necessary for the functionality of this service or enhance the user experience. Since these cookies either do not contain any personal data (e.g. language preference) or are very short-lived (e.g. session ID), cookies from this group are mandatory and cannot be deactivated.

Save selectionSelect all